InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: georgejjl post# 356592

Wednesday, 04/06/2022 7:03:24 PM

Wednesday, April 06, 2022 7:03:24 PM

Post# of 461665
This is very interesting and good news for AVXL

“] From the start of dosing to the end of the 30 day follow-up period, no serious adverse events occur and AF ceases within 12 hrs and does not recur.”

In all 4 patients, the A Fib and A flutter ceased in 12 hours from 1st dose - that is just amazing

Not sure where this goes but having this patent in hand is great.
Will M start a new trial on AFib ?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News